NCT06618586 Get Social Media and Risk-Reduction Training
| NCT ID | NCT06618586 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Virginia |
| Condition | Infant Death |
| Study Type | INTERVENTIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10,000 participants in total. It began in 2025-05-01 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines the implementation of the TodaysBaby™ mobile safe sleep intervention program in US hospitals. The main aims of this study are to examine: 1) differences in program penetration and the equity of penetration according to income and race/ethnicity; 2) differences in feasibility, acceptability, sustainability and fidelity top the intervention; and 3) the effectiveness of the intervention.
Eligibility Criteria
Inclusion Criteria: * Must speak English or Spanish * Must live in the United States * Must have given birth to a healthy, term infants (37 weeks or greater) and be discharged within 7 days of birth * Must plan to care for infant and live in the same household as infant after birth * Must enroll in the TodaysBaby program by the time their infant is 7 days of age Exclusion Criteria: * A prenatal diagnosis expected to have impact on infant care practices not compatible with study goals, such as supine infant sleep positioning.
Contact & Investigator
Rachel Y Moon, MD
PRINCIPAL INVESTIGATOR
University of Virginia School of Medicine
Frequently Asked Questions
Who can join the NCT06618586 clinical trial?
This trial is open to female participants only, studying Infant Death. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06618586 currently recruiting?
Yes, NCT06618586 is actively recruiting participants. Contact the research team at saroth@bu.edu for enrollment information.
Where is the NCT06618586 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06618586 clinical trial?
NCT06618586 is sponsored by University of Virginia. The principal investigator is Rachel Y Moon, MD at University of Virginia School of Medicine. The trial plans to enroll 10,000 participants.